MRKR MARKER THERAPEUTICS INC Earnings Reports 8-K Filing 2024 - Annual Meeting and Termination of Sales Agreement Marker Therapeutics, Inc. held its 2024 Annual Meeting of Stockholders, where three proposals were voted on and all were approved. The company also terminated its Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co. and RBC Capital Markets, LLC.Get access to all SEC 8-K filings of the MARKER THERAPEUTICS INC